This study is to identify potential markers from esophageal biopsies and brush cytology for feasibility of use in stool specimens for detection of Barretts Esophagus.
Study Type
OBSERVATIONAL
Enrollment
250
Mayo Clinic
Rochester, Minnesota, United States
to determine if assay of aberrantly methylated gene markers can discriminate Barrett's Esophagus tissue (and presence of dysplasia) from esophageal squamous and gastric cardia tissue.
we will plan to identify the best markers from highly selected marker candidates to differentiate between subjects who have BE and those who do not have BE.
Time frame: 1 day
Assess the accuracy of candidate markers in stool for detection of Barrett's Esophagus
Assess the ability of stool markers to distinguish between subjects who have BE and those who do not.
Time frame: One day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.